查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年细胞生物学市场预测：按产品、技术、应用、最终用户和地区分類的全球分析
市场调查报告书
商品编码
1383375

2030 年细胞生物学市场预测：按产品、技术、应用、最终用户和地区分類的全球分析

Cell Biology Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球细胞生物学市场规模将达206亿美元，预计2030年将达到590亿美元，预测期内年复合成长率为16.2%。

研究细胞（生命的基本组成部分）的科学领域称为细胞生物学，有时称为细胞学。细胞是生物体中发现的最小自主体，人们对其型态、功能和行为进行研究。此外，细胞生物学探索控制细胞如何发育、分裂、沟通以及与外界相互作用的复杂过程。包括新陈代谢、DNA 复製、基因表现、细胞讯号系统等的研究。

据GLOBOCAN称，癌症病例和癌症死亡人数预计将从2020年的1930万增加到2040年的近3000万。

政府资助和支持

细胞生物学研究需要政府的资助和支持，以促进科学发现、医学进步和生物技术发展。此外，政府也向学术机构、研究中心和生物技术公司提供资金，以支持研究工作、购买尖端设备和聘请科学家。此外，对基本细胞过程的更深入了解、尖端生物技术产品的开发以及细胞生物学发现的加速都可以在此类财政支持下实现。此外，政府的监督和伦理监管也确保了细胞生物学研究的道德性，特别关注伦理、法律和安全标准，最终造福整个社会，从而推动了市场规模的扩大。

高成本和专利问题

细胞生物学研究需要昂贵的设备、试剂和专业知识。此外，进行细胞生物学实验以及购买必要的设备和消耗品的高昂成本可能会阻碍资源的获取，特别是对于财力有限的小型研究机构和团体而言。此外，细胞生物学产品和技术的开发和商业化可能会受到智慧财产权和专利纠纷的阻碍。此外，在细胞生物学研究的某些领域，法律复杂性和所有权纠纷可能导致研究延误和财务损失。因此，这些因素可能会对市场规模产生负面影响。

新的创新工具和技术

由于技术的发展，细胞生物学的研究和应用正在改变。高解析度显微镜、单细胞定序和 CRISPR-Cas9 等基因编辑平台彻底改变了我们对细胞功能的理解。此外，借助这些工具，研究人员可以比以往更深入地探讨细胞，揭示复杂的分子过程，这些过程正在彻底改变遗传学、癌症研究、再生医学和药物研发发现领域。此外，透过自动化和巨量资料分析简化实验和资料处理，可以加快发现的速度。因此，细胞生物学的技术进步有可能扩大知识的边界并解决健康挑战，从而推动市场扩张。

标准化和缺乏熟练的专业人员

细胞生物学研究使用复杂的方案和技术，通常会导致变异性和重现性困难。此外，非标准化程序和实验环境的差异可能会阻碍结果的可靠性和可比性，从而可能对整个领域的进展产生负面影响。此外，细胞生物学某些领域缺乏合格的专家可能会减慢研究和产业成长的速度。

COVID-19 的影响

由于 COVID-19大流行，细胞生物学研究遇到了许多障碍。世界各地的实验室正在经历混乱，暂时关闭、进入实验室受到限制以及研究人员数量减少。此外，它还会导致正在进行的实验和资料收集的延迟和困难，从而减慢细胞生物学研究的速度。此外，COVID-19 研究比任何其他研究领域消耗更多的时间、金钱和人员，减缓了细胞生物学的进展。合作研究、思想共用和科学进步都受到旅行限制和社交距离政策的限制。因此，细胞生物学研究的正常运作和进展总体上受到了疫情的严重阻碍。

分子生物学试剂盒产业预计将在预测期内成为最大的产业

据估计，分子生物学试剂盒领域占据最大的市场份额，因为已经有多种试剂组和仪器可用于分子分析和生物分子的操作。许多分子生物学程序都需要这些工具，包括 DNA 和 RNA 萃取、PCR、基因表现分析和 DNA 定序。这些工具简化了实验室操作，使研究人员更容易准确、快速地进行测试。分子生物学试剂盒正在改变这个领域，使分子研究变得更加容易，并促进遗传、基因组和个人化医疗研究，以了解细胞功能及其如何影响健康和疾病。我们加深了对

基因编辑技术领域预计在预测期内年复合成长率最高

由于其强大的工具和技术可以精确操纵生物体的 DNA，基因编辑技术领域预计将在预测期内实现最高的年复合成长率。此外，常见的技术包括 TALEN、锌指核酸酶和 CRISPR-Cas9。这些技术可以对基因进行特定修饰，以研究基因功能、治疗遗传异常并创建用于研究和治疗目的的转基因生物体。此外，它还提供了对各种生物过程背后的分子机制的前所未有的见解，为遗传疾病治疗和生物技术应用的进步带来了巨大希望。因此，这些因素正在显着推动市场扩张。

比最大的地区

亚太地区在预测期内占据最大的市场占有率，这主要是由于医疗保健和研发基础设施的发展。此外，细胞生物学研究由澳洲国家健康与医学研究委员会资助，印度生物技术部倡议细胞生物学研究计画。我们提供协助和支持。此外，这些计画将增强科学能力，释放人才，鼓励尖端细胞生物学技术的发展，最终改善医疗保健，促进经济成长，推动亚太地区发展，这就是我的目标。

复合年复合成长率最高的地区：

预计北美在预测期内的年复合成长率最高。该地区是尖端研究中心，多所大学、研究机构和生物技术公司为细胞研究和创新制定了标准。此外，该地区对于个人化医疗、干细胞研究和基因编辑技术的发展至关重要，这些技术正在增进我们对疾病的理解并导致创新治疗方法的创造。此外，这个健康的生态系统不仅增强了科学理解，而且显着促进了全球细胞生物学市场的成长和竞争。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球细胞生物学市场：副产品

  • 显微镜和影像处理
    • 电子显微镜
    • 萤光显微镜
  • 细胞分析设备
  • 分子生物学试剂盒
  • 基于细胞的检测
  • 其他产品

第6章全球细胞生物学市场：依技术分类

  • 下一代定序（NGS）
  • 基因编辑技术
  • 生物资讯学和计算工具
  • 细胞培养及组织工程
  • 蛋白质体学和蛋白质分析
  • 其他技术

第7章全球细胞生物学市场：依应用分类

  • 神经科学
  • 免疫学
  • 干细胞研究
  • 遗传学和基因组学
  • 细胞疗法和免疫疗法
  • 病毒学
  • 其他用途

第8章全球细胞生物学市场：依最终用户分类

  • 合约研究组织（CRO）
  • 学术研究所
  • 医院和医疗保健提供者
  • 临床实验室
  • 製药和生物技术公司
  • 干细胞和再生医学公司
  • 其他最终用户

第9章全球细胞生物学市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Novartis
  • Pfizer
  • HiMedia Laboratories
  • BD Biosciences
  • Thermo Fisher Scientific
  • GE Healthcare Life Sciences
  • Vertex Pharmaceuticals
  • Qiagen
  • Illumina
  • Bio-Rad Laboratories
  • Lonza Group
  • Amgen
  • Roche
  • Johnson & Johnson
  • PerkinElmer
Product Code: SMRC24225

According to Stratistics MRC, the Global Cell Biology Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. The field of science that studies the basic building block of life, the cell, is called cell biology, sometimes referred to as cytology. The smallest autonomous entities found in living beings, cells, are studied in terms of their form, function, and behaviour. Moreover, cell biology explores the complex processes that control cell development, division, communication, and contact with the outside world. It includes research on metabolic, DNA replication, gene expression, and cell signalling systems.

According to GLOBOCAN, cancer cases would increase to almost 30 million by 2040, up from 19.3 million cases and ten million cancer deaths in 2020.

Market Dynamics:

Driver:

Government funding and support

Cell biology research requires government funding and support to advance scientific discovery, medical advancements, and biotechnological developments. Additionally, to support research efforts, buy cutting-edge equipment, and hire scientists, governments provide funding to academic institutions, research centers, and biotech firms. Moreover, a greater comprehension of basic cellular processes, the generation of cutting-edge biotechnological products, and an acceleration of cell biology discoveries are all made possible by this financial support. Furthermore, government monitoring and ethical rules also assist in ensuring that cell biology research is carried out ethically and with the highest care for ethical, legal, and safety standards, eventually benefiting society as a whole, thereby driving the market size.

Restraint:

High expenses and patent issues

Research in cell biology necessitates expensive equipment, reagents, and specialist knowledge. Moreover, access to resources may be hampered by the high expense of conducting cell biology experiments and buying the necessary equipment and supplies, especially for smaller research institutes or groups with little financing. Additionally, the development and commercialization of cell biology products and technology may be hampered by intellectual property rights and patent disputes. Furthermore, certain areas of cell biology research can experience delays and financial losses due to legal complications and ownership disputes. Hence, as a result, these factors may negatively impact market size.

Opportunity:

New Innovative tools and techniques

Cell biology research and applications have changed as a result of technological developments. High-resolution microscopy, single-cell sequencing, and gene editing platforms like CRISPR-Cas9 have all transformed our understanding of how cells function. Additionally, with the support of these tools, researchers can examine cells in unprecedented depth, revealing complex molecular processes that have revolutionized the fields of genetics, cancer research, regenerative medicine, and drug discovery. Furthermore, the speed of discovery has also been accelerated by the streamlining of experiments and data processing enabled by automation and big data analysis. Therefore, technology advancements in cell biology are advancing the boundaries of knowledge and have the potential to solve challenging health issues which thus propel the market expansion.

Threat:

Lack of standardization and skilled professionals

The use of complicated protocols and techniques in cell biology research frequently results in variability and difficulties with reproducibility. Moreover, the dependability and comparability of results can be hampered by unstandardized procedures and differences in experimental circumstances, which can have an adverse effect on the field's overall advancement. Furthermore, the rate of research and growth in the industry, however, may be slowed down by a lack of qualified professionals in certain fields of cell biology.

COVID-19 Impact

Cell biology research has suffered a number of obstacles as a result of the COVID-19 pandemic. Disruptions have affected laboratories all across the world, including temporary closures, access restrictions, and reduced worker numbers. Additionally, this has slowed down cell biology research by causing delays and difficulties in ongoing experiments and data collection. Moreover, COVID-19 research has taken up more time, money, and staff than other fields of study, which has slowed the progress of cell biology. Collaborations, the sharing of ideas and scientific advancements have all been hampered by the restrictions placed by travel restrictions and social distance-reducing policies. Therefore, the normal operation and advancement of cell biology research have generally been significantly hindered by the pandemic.

The Molecular Biology Kits segment is expected to be the largest during the forecast period

The Molecular Biology Kits segment is estimated to hold the largest share, due to a wide range of already prepared reagent kits and instruments intended for molecular analysis and molecular manipulation of biological molecules. These tools are necessary for many molecular biology procedures, including DNA and RNA extraction, PCR, gene expression analysis, and DNA sequencing. They make it easier for researchers to conduct tests accurately and quickly by streamlining and simplifying laboratory operations. By facilitating access to molecular studies and advancing genetic, genomic, and personalized medicine research, molecular biology kits have transformed the discipline and advanced our understanding of cellular functions and how they affect health and illness.

The Gene Editing Technologies segment is expected to have the highest CAGR during the forecast period

The Gene Editing Technologies segment is anticipated to have highest CAGR during the forecast period, due to potent tools and techniques that allow for precise manipulation of an organism's DNA. Additionally, popular methods include TALENs, zinc finger nucleases, and CRISPR-Cas9. In order to study gene function, treat genetic abnormalities, and produce genetically modified creatures for research or therapeutic purposes, these technologies enable specific modifications in genes. Furthermore, it has also provided previously unattainable insights into the molecular mechanisms underlying various biological processes and holds tremendous promise for the treatment of genetic diseases and the advancement of biotechnology applications. Therefore, these factors significantly propel the market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to infrastructure for healthcare and research and development are the main goals of these efforts. Additionally, Cell biology research is funded by the National Health and Medical Research Council of Australia and Department of Biotechnology in India provides funding and support for cell biology research initiatives. Furthermore, these programs seek to build scientific capacity, draw talent, and encourage the development of cutting-edge cell biology technology, ultimately enhancing healthcare, fostering economic growth, and boosting Asia-Pacific.

Region with highest CAGR:

North America is expected to witness highest CAGR over the projection period. It acts as the center for cutting-edge research, with several universities, research centers, and biotechnology firms setting the standard for cellular research and innovation. Additionally, the area has been essential in the development of personalized medicine, stem cell research, and gene editing technologies, which have advanced our understanding of diseases and led to the creation of innovative therapies. Furthermore, this healthy ecosystem has substantially boosted the growth and competitiveness of the global cell biology market, in addition to advancing scientific understanding.

Key players in the market

Some of the key players in the Cell Biology Market include: Novartis, Pfizer, HiMedia Laboratories, BD Biosciences, Thermo Fisher Scientific, GE Healthcare Life Sciences, Vertex Pharmaceuticals, Qiagen, Illumina, Bio-Rad Laboratories, Lonza Group, Amgen, Roche, Johnson & Johnson and PerkinElmer.

Key Developments:

In September 2023, Ginkgo Bioworks announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates.

In August 2023, Novartis announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based Biopharmaceutical Company focused on the discovery, development, and commercialization of precision medicines for kidney diseases.

In July 2023, Novartis' acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.

Products Covered:

  • Microscopy and Imaging
  • Cell Analysis Instruments
  • Molecular Biology Kits
  • Cell-based Assays
  • Other Products

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Gene Editing Technologies
  • Bioinformatics and Computational Tools
  • Cell Culture and Tissue Engineering
  • Proteomics and Protein Analysis
  • Other Technologies

Applications Covered:

  • Neuroscience
  • Immunology
  • Stem Cell Research
  • Genetics and Genomics
  • Cell Therapy and Immunotherapy
  • Virology
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Academic and Research Institutions
  • Hospitals and Healthcare Providers
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Stem Cell and Regenerative Medicine Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cell Biology Market, By Product

  • 5.1 Introduction
  • 5.2 Microscopy and Imaging
    • 5.2.1 Electron Microscopes
    • 5.2.2 Fluorescence Microscopes
  • 5.3 Cell Analysis Instruments
  • 5.4 Molecular Biology Kits
  • 5.5 Cell-based Assays
  • 5.6 Other Products

6 Global Cell Biology Market, By Technology

  • 6.1 Introduction
  • 6.2 Next-Generation Sequencing (NGS)
  • 6.3 Gene Editing Technologies
  • 6.4 Bioinformatics and Computational Tools
  • 6.5 Cell Culture and Tissue Engineering
  • 6.6 Proteomics and Protein Analysis
  • 6.7 Other Technologies

7 Global Cell Biology Market, By Application

  • 7.1 Introduction
  • 7.2 Neuroscience
  • 7.3 Immunology
  • 7.4 Stem Cell Research
  • 7.5 Genetics and Genomics
  • 7.6 Cell Therapy and Immunotherapy
  • 7.7 Virology
  • 7.8 Other Applications

8 Global Cell Biology Market, By End User

  • 8.1 Introduction
  • 8.2 Contract Research Organizations (CROs)
  • 8.3 Academic and Research Institutions
  • 8.4 Hospitals and Healthcare Providers
  • 8.5 Clinical Laboratories
  • 8.6 Pharmaceutical and Biotechnology Companies
  • 8.7 Stem Cell and Regenerative Medicine Companies
  • 8.8 Other End Users

9 Global Cell Biology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Novartis
  • 11.2 Pfizer
  • 11.3 HiMedia Laboratories
  • 11.4 BD Biosciences
  • 11.5 Thermo Fisher Scientific
  • 11.6 GE Healthcare Life Sciences
  • 11.7 Vertex Pharmaceuticals
  • 11.8 Qiagen
  • 11.9 Illumina
  • 11.10 Bio-Rad Laboratories
  • 11.11 Lonza Group
  • 11.12 Amgen
  • 11.13 Roche
  • 11.14 Johnson & Johnson
  • 11.15 PerkinElmer

List of Tables

  • Table 1 Global Cell Biology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cell Biology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Cell Biology Market Outlook, By Microscopy and Imaging (2021-2030) ($MN)
  • Table 4 Global Cell Biology Market Outlook, By Electron Microscopes (2021-2030) ($MN)
  • Table 5 Global Cell Biology Market Outlook, By Fluorescence Microscopes (2021-2030) ($MN)
  • Table 6 Global Cell Biology Market Outlook, By Cell Analysis Instruments (2021-2030) ($MN)
  • Table 7 Global Cell Biology Market Outlook, By Molecular Biology Kits (2021-2030) ($MN)
  • Table 8 Global Cell Biology Market Outlook, By Cell-based Assays (2021-2030) ($MN)
  • Table 9 Global Cell Biology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Cell Biology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 11 Global Cell Biology Market Outlook, By Next-Generation Sequencing (NGS) (2021-2030) ($MN)
  • Table 12 Global Cell Biology Market Outlook, By Gene Editing Technologies (2021-2030) ($MN)
  • Table 13 Global Cell Biology Market Outlook, By Bioinformatics and Computational Tools (2021-2030) ($MN)
  • Table 14 Global Cell Biology Market Outlook, By Cell Culture and Tissue Engineering (2021-2030) ($MN)
  • Table 15 Global Cell Biology Market Outlook, By Proteomics and Protein Analysis (2021-2030) ($MN)
  • Table 16 Global Cell Biology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 17 Global Cell Biology Market Outlook, By Application (2021-2030) ($MN)
  • Table 18 Global Cell Biology Market Outlook, By Neuroscience (2021-2030) ($MN)
  • Table 19 Global Cell Biology Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 20 Global Cell Biology Market Outlook, By Stem Cell Research (2021-2030) ($MN)
  • Table 21 Global Cell Biology Market Outlook, By Genetics and Genomics (2021-2030) ($MN)
  • Table 22 Global Cell Biology Market Outlook, By Cell Therapy and Immunotherapy (2021-2030) ($MN)
  • Table 23 Global Cell Biology Market Outlook, By Virology (2021-2030) ($MN)
  • Table 24 Global Cell Biology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Global Cell Biology Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Cell Biology Market Outlook, By Introduction (2021-2030) ($MN)
  • Table 27 Global Cell Biology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 28 Global Cell Biology Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 29 Global Cell Biology Market Outlook, By Hospitals and Healthcare Providers (2021-2030) ($MN)
  • Table 30 Global Cell Biology Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 31 Global Cell Biology Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 32 Global Cell Biology Market Outlook, By Stem Cell and Regenerative Medicine Companies (2021-2030) ($MN)
  • Table 33 Global Cell Biology Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.